Cargando…

Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells()()

Non–small cell lung carcinoma (NSCLC) is the most common cause of cancer deaths, with platin-based combination chemotherapy the most efficacious therapies. Gains in overall survival are modest, highlighting the need for novel therapeutic approaches including the development of next-generation platin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bar, Jair, Hasim, Mohamed S., Baghai, Tabassom, Niknejad, Nima, Perkins, Theodore J., Stewart, David J., Sekhon, Harmanjatinder S., Villeneuve, Patrick J., Dimitroulakos, Jim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031866/ https://www.ncbi.nlm.nih.gov/pubmed/27659012 http://dx.doi.org/10.1016/j.neo.2016.07.004

Ejemplares similares

Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer()()
por: Hasim, Mohamed S., et al.
Publicado: (2018)

Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer
por: Howe, Grant A., et al.
Publicado: (2016)

Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells
por: Ma, Laurie, et al.
Publicado: (2012)

Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination
por: St Germain, Carly, et al.
Publicado: (2010)

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study
por: Kumar, Srishti, et al.
Publicado: (2022)

Do fine needle aspirate cytomorphological features correlate with positron emission tomography findings of metastatic non‐small cell lung carcinoma in lymph nodes?
por: Keyhanian, Kianoosh, et al.
Publicado: (2023)

The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells
por: Weberpals, Johanne I, et al.
Publicado: (2011)

Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers
por: Schlosser, Kenny, et al.
Publicado: (2016)

Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma
por: Keyhanian, Kianoosh, et al.
Publicado: (2022)

Independent transcriptional reprogramming and apoptosis induction by cisplatin
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Bilateral Vocal Cord Paralysis and Cervicolumbar Radiculopathy as the Presenting Paraneoplastic Manifestations of Small Cell Lung Cancer: A Case Report and Literature Review
por: Yeung, Jeffrey C., et al.
Publicado: (2016)

Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells
por: Sulaiman, Andrew, et al.
Publicado: (2020)

A Contemporary Report of Clinical Outcomes in Patients with Melanoma Brain Metastases
por: Phillips, William J., et al.
Publicado: (2021)

Induction of senescence in primary glioblastoma cells by serum and TGFβ
por: Kumar, Ritesh, et al.
Publicado: (2017)

An Algorithmic Approach for Assessment of Mediastinal Lesions Using Conventional Transbronchial Needle Aspiration and Endoscopic Ultrasonography in a Single Procedure
por: Burkett, Andrew, et al.
Publicado: (2017)

Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
por: Mortensen, Anja Charlotte Lundgren, et al.
Publicado: (2020)

Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.
por: Zaffaroni, N., et al.
Publicado: (1998)

Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin-Resistant Ovarian Cancer Cells (A2780)
por: Jafarzadeh, Samira, et al.
Publicado: (2021)

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells
por: BAO, LINGJIE, et al.
Publicado: (2015)

Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells
por: Nehmé, A, et al.
Publicado: (1999)

Transcriptomically Guided Mesendoderm Induction of Human Pluripotent Stem Cells Using a Systematically Defined Culture Scheme
por: Carpenedo, Richard L., et al.
Publicado: (2019)

Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cells.
por: Borner, M. M., et al.
Publicado: (1997)

Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study
por: Quimby, Alexandra E., et al.
Publicado: (2018)

Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis
por: El-Naa, Mona Mohamed, et al.
Publicado: (2016)

Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
por: Zhao, Tong T., et al.
Publicado: (2010)

Increased Autophagy Levels Mediate Cisplatin Resistance in Cisplatin-Resistant Cells While Also Rendering Them Vulnerable to Autophagy Induction
por: Duan, Guihua, et al.
Publicado: (2018)

Implementing Arithmetic and Other Analytic Operations By Transcriptional Regulation
por: Cory, Sean M., et al.
Publicado: (2008)

Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma
por: Chavez-Dominguez, Rodolfo, et al.
Publicado: (2023)

Role of dendritic cells in the induction of regulatory T cells
por: Kushwah, Rahul, et al.
Publicado: (2011)

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
por: Zhang, Yuan, et al.
Publicado: (2019)

Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction
por: Zhao, Fuguang, et al.
Publicado: (2020)

Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer
por: Palka, Magda, et al.
Publicado: (2017)

Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis
por: Ballout, Farah, et al.
Publicado: (2022)

Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995)

Direct Induction of Hematoendothelial Programs in Human Pluripotent Stem Cells by Transcriptional Regulators
por: Elcheva, Irina, et al.
Publicado: (2014)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

Induction of human neuronal cells by defined transcription factors
por: Pang, Zhiping P., et al.
Publicado: (2011)

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
por: Michel, P, et al.
Publicado: (2006)

Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction
por: Li, Hecheng, et al.
Publicado: (2009)

Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer
por: Date, H, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_s23a5oqdekai7bp5nh4a4fih11